Therefore, on the whole, the presence of both TNFα and TGFβ1 at tumor sites, combined with the factors they induce in MSCs (as we have demonstrated), may have pro-malignancy effects that act on the TME as well as directly on the cancer cells, to promote their pro-invasive potential. The gene discussed is TNF; the disease is cancer.